KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
[Psilocybin compared with escitalopram for depression].Ned Tijdschr GeneeskdPMID 35138714无 PMCID2022-Jan-170.98未发现恶性肿瘤人群证据。待处理
Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens.Int J CancerPMID 34528705PMC86274682022-Jan-150.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.LancetPMID 34953526PMC87002832022-Jan-150.98未发现恶性肿瘤人群证据。待处理
The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.BloodPMID 34758069无 PMCID2022-Jan-130.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.JAMAPMID 35015037PMC87535082022-Jan-110.98未发现恶性肿瘤人群证据。待处理
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.J Clin OncolPMID 34648352无 PMCID2022-Jan-101.00命中用户提供的消化道肿瘤阳性参考集。待处理
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.J Clin OncolPMID 34793245PMC87181752022-Jan-100.98未发现恶性肿瘤人群证据。待处理
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma.J Clin OncolPMID 34818112PMC87182242022-Jan-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology.J Hematol OncolPMID 35012610PMC87440642022-Jan-100.98未发现恶性肿瘤人群证据。待处理
The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial.Dis EsophagusPMID 34155501无 PMCID2022-Jan-070.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.N Engl J MedPMID 34986284无 PMCID2022-Jan-060.95The study meets most criteria (randomized, phase 3, drug intervention, time-to-event endpoint, original result) but is not an oncology study; it is for severe aplastic anemia, a non-malignant hematologic condition. Therefore, it is excluded from the oncology Kaplan-Meier digitization cohort.待处理
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.N Engl J MedPMID 34986285PMC98445132022-Jan-060.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication.N Engl J MedPMID 34986286PMC76122002022-Jan-060.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2).Mod RheumatolPMID 33274687无 PMCID2022-Jan-050.98未发现恶性肿瘤人群证据。待处理
Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.JAMA Netw OpenPMID 35084480PMC87960172022-Jan-040.95The study meets most criteria (Phase III, randomized, oncology, human, drug intervention, original result) but does not have a primary/key secondary time-to-event efficacy endpoint. The primary endpoint is a count of days of neutropenia, and other endpoints are safety, infection rates, and patient-reported outcomes, none of which are time-to-event efficacy measures.待处理
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).VaccinePMID 34507861无 PMCID2022-Jan-030.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia: stage 2 results from a multicenter phase III study.PlateletsPMID 33251910无 PMCID2022-Jan-020.90The study is a Phase III randomized trial of a drug for chronic immune thrombocytopenia, but it is not an oncology/malignant neoplasm study and does not have a time-to-event primary/key secondary endpoint.待处理
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial.HaematologicaPMID 33297668PMC87190652022-Jan-010.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.Ann SurgPMID 33630475无 PMCID2022-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Positron Emission Tomography-Guided Bone Marrow-Sparing Radiation Therapy for Locoregionally Advanced Cervix Cancer: Final Results From the INTERTECC Phase II/III Trial.Int J Radiat Oncol Biol PhysPMID 34419564PMC86882212022-Jan-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).Int J CancerPMID 34431518无 PMCID2022-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Vitamin D Supplementation Improves Fasting Insulin Levels and HDL Cholesterol in Infertile Men.J Clin Endocrinol MetabPMID 34508607无 PMCID2022-Jan-010.98未发现恶性肿瘤人群证据。待处理
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy - naive adults with HIV-1 infection.AIDSPMID 34534138PMC86542482022-Jan-010.98未发现恶性肿瘤人群证据。待处理
Efficacy of Prucalopride for Chronic Idiopathic Constipation: An Analysis of Participants With Moderate to Very Severe Abdominal Bloating.Am J GastroenterolPMID 34585675PMC87159962022-Jan-010.98未发现恶性肿瘤人群证据。待处理
Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study.J Clin OncolPMID 34606378PMC86832402022-Jan-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial.JAMA CardiolPMID 34643642PMC85152582022-Jan-010.98未发现恶性肿瘤人群证据。待处理
Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial.JAMA OncolPMID 34695841PMC85466202022-Jan-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease.JAMA NeurolPMID 34807243PMC86094652022-Jan-010.98未发现恶性肿瘤人群证据。待处理
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.Int J Radiat Oncol Biol PhysPMID 34919884PMC87892172022-Jan-010.95This is a randomized Phase 3 trial in oncology with original results, but it compares two radiotherapy dose levels (70.2 Gy vs 79.2 Gy) without a drug-containing intervention. Furthermore, the primary endpoints are patient-reported quality-of-life outcomes, not a time-to-event efficacy endpoint like OS, PFS, DFS, etc. Therefore, it does not meet the criteria for a Kaplan-Meier digitization cohort.待处理
Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomes.Pediatr ResPMID 33658655PMC84133972022-Jan0.98未发现恶性肿瘤人群证据。待处理
Methodology of the fatigue after stroke educational recovery group randomized controlled trial.Int J StrokePMID 33724101无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors.Diabetes Metab JPMID 33866774PMC88318072022-Jan0.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration.OphthalmologyPMID 33957183无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.Br J DermatolPMID 33991341PMC92919442022-Jan0.95The study is a randomized Phase III trial with a drug intervention (risankizumab) and reports original efficacy results. However, it evaluates plaque psoriasis, which is a non-oncological condition. Therefore, it does not meet the primary oncology eligibility criterion.待处理
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status.AllergyPMID 33993501PMC92901362022-Jan0.98未发现恶性肿瘤人群证据。待处理
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.Arthritis RheumatolPMID 34164944PMC93000992022-Jan0.98未发现恶性肿瘤人群证据。待处理
A randomized phase 3 study of ixazomib-dexamethasone versus physician's choice in relapsed or refractory AL amyloidosis.LeukemiaPMID 34168284PMC87272922022-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
RESUME-1: a Phase III study of tolperisone in the treatment of painful, acute muscle spasms of the back.Pain ManagPMID 34192885无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial.Clin Lung CancerPMID 34226144无 PMCID2022-Jan0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Assessing the ability of boys with Duchenne muscular dystrophy age 4-7 years to swallow softgel capsules: Clinical trial experience with edasalonexent.J Clin Pharm TherPMID 34263472无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial.Br J DermatolPMID 34289086PMC92983282022-Jan0.98未发现恶性肿瘤人群证据。待处理
Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration.Am J OphthalmolPMID 34289338无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma.LeukemiaPMID 34304248PMC87273012022-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial.Ann Surg OncolPMID 34324113无 PMCID2022-Jan0.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial.J Am Acad DermatolPMID 34343599无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07.Gastric CancerPMID 34351555无 PMCID2022-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.J Am Acad DermatolPMID 34416294无 PMCID2022-Jan0.98未发现恶性肿瘤人群证据。待处理
Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.Lancet Respir MedPMID 34454653无 PMCID2022-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.Gastric CancerPMID 34468869PMC87329412022-Jan0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases.J Pathol Clin ResPMID 34480530PMC86829402022-Jan0.85The record describes a randomized Phase III oncology trial in humans (EORTC 40983). However, the outcomes assessed are histopathological growth patterns and tumor regression grading, which are biomarkers, not the required survival, progression, recurrence, death, or time-to-event efficacy outcomes. Therefore, it is excluded.待处理